Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Friday 15 May, 2015

GlaxoSmithKline PLC

Director/PDMR Shareholding

RNS Number : 3905N
GlaxoSmithKline PLC
15 May 2015
 

GlaxoSmithKline plc

 

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

 

I give below details of changes in interests in the Ordinary shares of GlaxoSmithKline plc in respect of the under-mentioned Executive Director on 14 May 2015:

 

 

GSK Deferred Annual Bonus Plan

 

Sir Andrew Witty

 

 

 

Exercise of a nil priced option over 57,932 shares and 7,821 shares granted on 9 March 2012, both of which vested on 9 March 2015 under the GlaxoSmithKline Deferred Annual Bonus Plan. GlaxoSmithKline delivered the net of tax value in shares being 34,849.

 

The fair market value of an Ordinary Share at the point of exercise on 14 May 2015 was £14.14.

 

The Company and the above-mentioned Executive Director were advised of this transaction on 15 May 2015.

 

This notification relates to a transaction notified in accordance with paragraph 3.1.4R(1)(a) of the Disclosure and Transparency Rules.

 

 

V A Whyte

Company Secretary

 

15 May 2015

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQELFFEEFFBBF

a d v e r t i s e m e n t